Contact:
Karen Whelan, Public Relations & Practice Marketing Specialist
508-787-1461
kwhelan@optos.com
Optos to Participate in SECO International
2/20/2007
MARLBOROUGH, MA, February 20, 2007 – Optos, a leading medical technology company for the design, development, manufacturing, and marketing of retinal imaging devices, will host key educational activities at the SECO International taking place in Atlanta, GA, February 21-25, 2007.
Optos will hold two sessions of its Optos Academy meeting while at SECO. A popular workshop series, the Optos Academy is for Optos Partners and other interested doctors which will highlight techniques and best practices created to enable clinicians to achieve the highest level of success with Optos’ technology. The first Optos Academy will be on Thursday, February 22nd from 7:30 pm to 8:30 pm. Highly-regarded speaker, Jeffry Gerson, OD, FAAO, will provide an educational presentation titled, “Contemporary Care of the Diabetic Patient,” and will focus on various topics related to treating patients with diabetes.
"With the explosion in the number of diabetics, education is key to help with basic understanding of the disease process, ocular findings, and the importance of early detection through eye exams’ diabetic findings and patient education are significantly enhanced with an optomap® Retinal Exam,” stated Dr. Gerson.
The second Optos Academy will be a breakfast meeting held on Saturday, February 24th from 6:30 am to 8:00 am. Esteemed speaker, William Jones, OD, FAAO, will give his popular lecture titled, “Retina Grand Rounds.” Attendees will get a sneak-preview of Optos’ newest software v2.3, which will be available to Partners shortly. A presentation titled, “Review of the optomap® plus Medical Retinal Exam for Reimbursable Procedures,” will be presented by Optos personnel.
SECO attendees are also encouraged to attend a course by Scot Morris, OD, FAAO, titled, “Retinal Disease Detection Using Digital Imaging,” sponsored by Optos on Friday, February 23rd from 8:00 am to 10:00 am.
Representatives from Optos will be at its booth, #222, throughout SECO to meet with Optos Partners as well as educate interested attendees on Optos’ technology. Optos encourages attendees to stop by its booth to receive a complimentary optomap® Retinal Exam and learn how this innovative technology – used by more than 2,500 eye care practitioners worldwide – helps with the detection and diagnosis of both eye and non-eye related conditions.
Note to Editors
Optos plc is a leading and rapidly growing medical technology company for the design, development, manufacturing and marketing of devices that image the retina, the light-sensitive area at the back of the eye. Optos' platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image - branded the optomap® Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina, such as glaucoma, diabetic retinopathy and age-related macular degeneration.
The Company has gained regulatory clearance (CE and FDA 510(k)) to market a second device - P200MA. The P200MA is aimed at the specialist ophthalmic and medical as opposed to the primary care market. It is designed to produce an angiographic retinal image called optomap® fa that supports medical procedures by providing enhanced diagnostic, monitoring and treatment capabilities. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as diabetes, hypertension and certain cancers. Optos’ technology provides an unequalled combination of wide-field retinal imaging, speed and convenience for both practitioner and patient and can help save sight and save lives.
Optos estimates that its P200 device is targeting a recurring US$2 billion market opportunity. As at 30 September 2006 Optos had 232 employees serving more than 2,500 customers in the Company’s existing markets, currently the USA, Canada, UK and Germany. Optos plc is headquartered in Dunfermline, Scotland and was admitted to the Main Market of the London Stock Exchange on 15 February 2006 trading under the symbol OPTS.
Optos is incorporated in Scotland under the Companies Act 1985 with registered number SC139953. The Company maintains its Registered Office at Queensferry House, Carnegie Business Campus, Dunfermline, Scotland KY11 8GR United Kingdom.